New patent expiration for Merck Sharp drug PREVYMISBy DrugPatentWatch – Make Better Decisions / May 22, 2024 Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…Source